[go: up one dir, main page]

FI951702L - Farmaceutisk komposition för behandling av osteoporos - Google Patents

Farmaceutisk komposition för behandling av osteoporos Download PDF

Info

Publication number
FI951702L
FI951702L FI951702A FI951702A FI951702L FI 951702 L FI951702 L FI 951702L FI 951702 A FI951702 A FI 951702A FI 951702 A FI951702 A FI 951702A FI 951702 L FI951702 L FI 951702L
Authority
FI
Finland
Prior art keywords
treating osteoporosis
pharmaceutical method
pharmaceutical
osteoporosis
treating
Prior art date
Application number
FI951702A
Other languages
English (en)
Finnish (fi)
Other versions
FI951702A0 (sv
Inventor
Hiroyasu Tobe
Kazuyuki Kitamura
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of FI951702A0 publication Critical patent/FI951702A0/sv
Publication of FI951702L publication Critical patent/FI951702L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
FI951702A 1994-04-12 1995-04-10 Farmaceutisk komposition för behandling av osteoporos FI951702L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7323094 1994-04-12

Publications (2)

Publication Number Publication Date
FI951702A0 FI951702A0 (sv) 1995-04-10
FI951702L true FI951702L (sv) 1995-10-13

Family

ID=13512179

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951702A FI951702L (sv) 1994-04-12 1995-04-10 Farmaceutisk komposition för behandling av osteoporos

Country Status (13)

Country Link
US (1) US5604263A (sv)
EP (1) EP0677289B1 (sv)
KR (1) KR950031059A (sv)
AT (1) ATE175575T1 (sv)
AU (1) AU696334B2 (sv)
CA (1) CA2146820A1 (sv)
DE (1) DE69507185T2 (sv)
DK (1) DK0677289T3 (sv)
ES (1) ES2129691T3 (sv)
FI (1) FI951702L (sv)
HU (1) HUT71604A (sv)
NO (1) NO951422L (sv)
TW (1) TW427901B (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205151B2 (en) * 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US7666449B2 (en) * 2001-06-20 2010-02-23 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US7270835B2 (en) * 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US20040115290A1 (en) * 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7901714B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US20040219240A1 (en) * 2001-06-20 2004-11-04 Babish John G. Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US7901713B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US20090263522A1 (en) * 2001-10-26 2009-10-22 Babish John G Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2
US7279185B2 (en) 2001-10-26 2007-10-09 Metaproteonics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
CN1870983B (zh) * 2002-02-14 2010-12-01 麒麟麦酒株式会社 用于改善脂质代谢的组合物和食品
AU2003286549B2 (en) * 2002-10-21 2006-11-30 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
JP2005104951A (ja) * 2003-01-17 2005-04-21 Kirin Brewery Co Ltd 血圧降下用組成物および血管柔軟性改善用組成物並びにこれらの機能が付与された食品
EP1626731B1 (en) * 2003-05-22 2009-01-21 Metaproteomics, LLC Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
US20050192356A1 (en) * 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
CA2618613A1 (en) * 2005-08-09 2007-02-22 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
US20070154576A1 (en) * 2005-12-09 2007-07-05 Tripp Matthew L Protein kinase modulation by hops and Acacia products
US20080051466A1 (en) * 2006-06-20 2008-02-28 Metaproteomics, Llc Isoalpha acid based protein kinase modulation cancer treatment
WO2007149482A2 (en) * 2006-06-20 2007-12-27 Metaproteomics, Llc Xanthohumol based protein kinase modulation cancer treatment
EP2626077A3 (en) * 2007-03-19 2013-11-20 Metaproteomics, LLC Compositions for promoting bone and joint health
KR20100029201A (ko) 2007-05-11 2010-03-16 메타프로테오믹스, 엘엘씨 중금속 해독 방법 및 조성물
CA2708613A1 (en) * 2007-12-10 2009-06-18 Metaproteomics, Llc Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith
KR20110010603A (ko) * 2008-04-02 2011-02-01 메타프로테오믹스, 엘엘씨 치환된 1,3-시클로펜타디온 약독화 내피 염증 및 내피-모노사이트 상호작용
WO2019158983A1 (en) * 2018-02-16 2019-08-22 The New Zealand Institute For Plant And Food Research Limited Oral dosage forms comprising a hops extract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892808A (en) * 1965-11-17 1975-07-01 Carlton & United Breweries Hop extracts
DE1901277A1 (de) * 1969-01-10 1970-08-06 Partipharm Ag Mittel zur Kompensation uebermaessigen Zigarettenkonsums
US5370863A (en) * 1992-12-16 1994-12-06 Miller Brewing Company Oral care compositions containing hop acids and method
JPH06312924A (ja) * 1993-04-28 1994-11-08 Asahi Breweries Ltd 抗酸化作用を有するフムロン類の利用

Also Published As

Publication number Publication date
DE69507185T2 (de) 1999-09-09
FI951702A0 (sv) 1995-04-10
EP0677289B1 (en) 1999-01-13
HU9501043D0 (en) 1995-06-28
ATE175575T1 (de) 1999-01-15
AU696334B2 (en) 1998-09-10
NO951422L (no) 1995-10-13
CA2146820A1 (en) 1995-10-13
HUT71604A (en) 1996-01-29
KR950031059A (ko) 1995-12-18
DK0677289T3 (da) 1999-09-06
DE69507185D1 (de) 1999-02-25
EP0677289A3 (en) 1996-10-23
US5604263A (en) 1997-02-18
AU1638495A (en) 1995-10-19
EP0677289A2 (en) 1995-10-18
TW427901B (en) 2001-04-01
NO951422D0 (no) 1995-04-11
ES2129691T3 (es) 1999-06-16

Similar Documents

Publication Publication Date Title
FI951702L (sv) Farmaceutisk komposition för behandling av osteoporos
FI952996L (sv) Förfarande för avfallsbehandling
FI971568L (sv) Förfarande för behandling av resistenta tumörer
IS4812A (is) Samsett meðferð fyrir beingisnun
FI960869L (sv) Förfarande för konditionering av substanser
FI960281L (sv) Förfarande för sterilisering av produkter
DE69722961D1 (de) Verfahren zum herstellen von individuell angepassten medizinischen vorrichtungen
NO950275D0 (no) Kombinasjonsbehandling for osteoporose
SG50018A1 (en) Method for developing treatment
FI941866L (sv) Förfarande för fraktionering av en lösning
FI951856L (sv) Farmaceutisk komposition för behandling av osteoporos
FI962069L (sv) Förfarande för framställning av karpolaktam
FI954423L (sv) Förfarande för rening av taxoider
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
LV11745A (lv) Metode nepartrauktai misas varisanai
FI20050181L (sv) Förfarande för att framställa 21-klorkortikosteroider
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
FI951903L (sv) Förfarande för framställning av ginkgolid B ur ginkolid C
FI955800L (sv) Metod att framställa aminoalkylguanidiner
BR9502171A (pt) Sistema de lastro para máquina de compactação
FI973173L (sv) Förfarande för behandling av kondensat
FI963018L (sv) Förfarande för framställning av gammapyroner
DE69500952D1 (de) Solebehandlungsmethode
FI964410L (sv) Förfarande för framställning av 4-amino-delta4-3-ketosteroider genom 4-nitro-delta4-3-ketosteroider
ID16924A (id) Metode perlakuan poliolefin